PolarityTE

$0.682
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0433 (+6.68%) Today

-$0.0095 (-1.37%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell PolarityTE and other stocks, options, and ETFs commission-free!

About PTE

PolarityTE, Inc. Common Stock, also called PolarityTE, is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT. The listed name for PTE is PolarityTE, Inc. Common Stock.

CEO

David Seaburg

Employees

157

Headquarters

Salt Lake City, Utah

Founded

1998

Market Cap

27.14M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

3.40M

High Today

$0.716

Low Today

$0.6401

Open Price

$0.66

Volume

2.09M

52 Week High

$4.60

52 Week Low

$0.553

Collections

PTE News

ReutersNov 23

Utah biotech company wins dismissal of shareholder lawsuit

A federal judge has dismissed a shareholder lawsuit accusing Salt Lake City, Utah-based biotech company PolarityTE Inc of misleading investors about the prospec

BenzingaNov 23

Why PolarityTE's Stock Is Trading Lower Today

PolarityTE (NASDAQ: PTE) shares are trading lower on Monday after the company reduced the exercise price of warrants from $2.80 per share to 10 cents per share.

PTE Earnings

-$1.18

-$0.79

-$0.39

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market